Editorial: The impact of the DNA damage response on anti-tumor immunity

Front Immunol. 2022 Sep 27:13:1026194. doi: 10.3389/fimmu.2022.1026194. eCollection 2022.

Authors

Gang Chen¹, Shengtao Zhou², Chaoyang Sun¹, Leng Han³

Affiliations

¹ National Clinical Research Center for Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² West China Second University Hospital, Sichuan University, Chengdu, China.
³ Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States.

No abstract available

Keywords: DDR-targeting therapy; DNA damage response; Immune checkpoint blockade; Immunotherapy; onco-immunology.

Publication types

Editorial

MeSH terms

Antineoplastic Agents, Immunological*
DNA Damage
Immunotherapy*

Substances

Antineoplastic Agents, Immunological